By Benjamin Goad - 08/19/13 11:40 AM EDT
JPMorgan Chase’s regulatory headaches continue to pile up, The Wall Street Journal reports.
Public health groups are incensed over delays in the Food and Drug Administration’s approval of new ingredients for sunscreen, RegWatch reports.
For better or worse, the regulatory state has continued its expansion during the Obama administration, according to RegWatch.
Send all of your comments, complaints and regulatory news tips to RegWatch via email@example.com or firstname.lastname@example.org.